Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...

CFO Vanessa Kanu reported Q4 adjusted EBITDA of $195 million, representing a 9% increase year-over-year. She attributed the 27% increase in adjusted diluted EPS to strong margins and a lower tax rate ...

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's disease ONAPGO is a wearable subcutaneous infusion ...